# Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis

> **NCT07721142** · PHASE4 · RECRUITING · sponsor: **Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine** · enrollment: 300 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** Kunxian Capsule
- **DRUG:** Kunxian Capsule Placebo

## Key facts

- **NCT ID:** NCT07721142
- **Lead sponsor:** Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-15
- **Primary completion:** 2028-03-15
- **Final completion:** 2028-03-15
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07721142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07721142, "Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07721142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*